FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.
FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.
By Madison Czopek | PolitiFact
Share
Save
Lowering the prices of prescription drugs has been high on United States President Donald Trump’s agenda since he took office in January. He has taken a number of steps, including striking deals with pharmaceutical companies, to lower the costs of prescription drugs.
It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to…
Caught in a standoff with the US president, who wants to lower the cost of medical treatments in the US, pharmaceutical companies…
US president has pitched initiative as populist attack on pharmaceutical companies, but analysts question efficacy.
President Donald Trump has pushed to lower drug prices for Americans, which are on average nearly three times higher than…
President Trump and top health officials announced a deal with Pfizer to try to lower Medicaid prices, and a website to help…
US-Präsident Trump fordert seit längerem günstigere Medikamentenpreise in seinem Land. Im Mai unterzeichnete er ein…
